— Know what they know.
Not Investment Advice

BHST NASDAQ

BioHarvest Sciences Inc. Common Stock
1W: +2.1% 1M: -11.3% 3M: -11.9% YTD: -24.8% 1Y: -39.7%
$3.92
-0.04 (-1.01%)
Pre-Market: $4.13 (+0.21, +5.48%)
Weekly Expected Move ±5.9%
$4 $4 $4 $4 $5
NASDAQ · Basic Materials · Agricultural Inputs · Alpha Radar Strong Sell · Power 38 · $67.9M mcap · 15M float · 0.192% daily turnover · Short 19% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$67.9M
52W Range3.57-12.8
Volume14,481
Avg Volume27,975
Beta1.37
Dividend
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOIlan Sobel
Employees87
SectorBasic Materials
IndustryAgricultural Inputs
IPO Date2021-01-08
1140-625 Howe Street
Vancouver, BC V6C 2T6
CA
(604) 622-1186
About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms